Erkim Signs Agreement with Diurnal for the Distribution of ALKINDI® and CHRONOCORT® in Turkey

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases,...

Jan 24, 20212 min read

AnGes and Er-Kim enter into an agreement for the commercialization of Collategene® in Turkey

October 8, 2020, AnGes, Inc., a Japanese biopharmaceutical company focused on gene-based medicines and Er-Kim, a leading Turkish...

Oct 14, 20203 min read

Our Board Members answered questions from Milliyet on Turkey's place in global pharma industry.

May 7, 20201 min read

Our CEO was featured on the first issue of fast company Turkey.

Apr 6, 20201 min read